Johnny Duerinck (Recipient)

GLITIPNI:a phase 1b clinical trial combining surgical resection with direct intracerebral injection of immune checkpoint inhibitors in patients with recurrent glioblastoma) with Platform presentation of the abstract at 24th Annual Meeting of the Society for Neuro-Oncology in Phoenix, Arizona
Awarded date24 Nov 2019

ID: 48472555